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Su, Hengjie. M.S. The University of Memphis. May 2014. A Novel 
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Membrane. Major Professor: Dr. Joel D. Bumgardner. 
Guided bone regeneration (GBR) membranes function as barriers in preventing 
soft tissue migration into dental osteogenic spaces. Chitosan is a biocompatible and 
degradable natural polysaccharide, which has shown potential in tissue regeneration 
and GBR applications. Trifluoroacetic acid (TFA) is a common solvent used to make 
the chitosan polymer solution for electrospinning process. However, the TFA salts 
remaining in the electrospun nano-sized fibers induce the chitosan fiber swelling and 
dissolution when placed in aqueous solutions leading to loss of nano-fiber structure. 
The aim of this work was to evaluate an innovative method using triethylamine 
(TEA)/ di-tert-butyl dicarbonate (tBoc) to treat the electrospun chitosan membrane 
without losing nanofibrous structure or compromising compatibility. After the 
treatment, the nanofibrous structure was well maintained in water overnight, which 
was confirmed by the SEM. FTIR analyses confirmed TFA salt removal. Surgical 
fixation tests indicated TEA/tBoc membranes have appropriate clinical handability. 
The TEA/tBoc treated membrane also showed good cytocompatibility with 
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CHAPTER 1: INTRODUCTION 
1.1 Current clinical problem 
Guided bone regeneration (GBR) membranes are a critical biomaterial related 
device in tissue engineering. They are widely employed in dental/maxillofacial 
treatments combined with bone graft to regenerate the defect of cementum, 
periodontal ligament, and alveolar bone due to chronic periodontitis, edentulism, or 
traumatic injury.1 These membranes are used to direct the formation of bone in the 
surgical sites and act as barriers to fast proliferating soft tissues to prevent their 
migration into the bone graft site.2  
Periodontitis is one of the most emphasized and researched dental condition 
related to GBR membranes applications. Periodontitis is a prevalent disease occurring 
globally and is characterized by periodontal tissue destruction, especially in bone loss 
and further damage showed as tooth loss.3 It is reported that approximately one half of 
adults older than 30 years have periodontitis in the United State.3 In 2006, over 5 
million dental implants, valued over $150 million, were placed in the US due to 
periodontitis, and number of implants placed per year is expected to increase due both 
to the aging world population and the success of implant therapies.4 The goal of the 
therapy for periodontitis is to reconstruct periodontal supporting structure in both 
architecture and function as well as to prevent the further attachment and bone loss.5 
Early in 1980s, experimental studies showed that placement of GBR membranes had 
considerable positive effects on bone formation and these reported effects were much 
better in comparison to no membrane placement in between the gingival tissue and 
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the bone graft.5, 6 During the surgery, an occlusive GBR membrane is placed into the 
defect site as a barrier to exclude the gingiva tissue migrating into the lesion, to 
protect the regenerating bone tissues and graft materials and to prevent formation of 
vertical deep crevices in between the mandible and the tooth (Fig. 1).5, 7, 8 Once 
implanted the GBR membrane, typical healing response occurs in which cells located 
in and around the surgical site adjacent to the tooth/bone tissues migrate in to the 
protected space and the graft materials and grow and differentiate into new supporting 
tissues including functional new bone, periodontal ligament and cementum.8 GBR 
membranes are also employed for the restoration of reduced alveolar bone adjacent to 





Fig. 1. The GBR membrane is in the application of supporting structure repair. a. 
vertical deep crevice in the mandible b. the GBR membrane is embedded in between 
the mucosal flap and the debrided lesion c. the membrane start to degrade after 3-5 







Fig. 2. The GBR membrane is in the application of alveolar restoration. a. 
defected alveolar b. after debriding the defect, the membrane and bone scaffold are 
placed to help the tissue regeneration c. the membrane is shaped and stabilized to 





1.2 Current GBR membranes 
Current membranes in clinical application are classified as non-absorbable 
membranes, such as polytetrafluoroethylene (ePTFE) membranes (e.g. Gore-Tex®), 
and biodegradable membranes based on different synthetic degradable polymers such 
as polyglactin membranes (e.g. Vicryl®), polyglycolic and polylactic acid (PGA/PLA 
Copolymer) membranes (e.g. Resolut Adapt®) and biopolymer collagen-based 
membranes (e.g. Biomesh® / Helisorb®).9, 10 The difference in these two types of GBR 
membranes are the non-absorbable membranes require a second surgery for 
removal.11 In contrast with non-absorbable membranes, absorbable membranes 
degrade during the healing process, and thus do not need another surgical intervention 
for removal.12, 13, 14 Therefore, absorbable membranes have become common because 
of their benefit in clinical operation12, 13, 14. Compared with non-degradable ePTFE 
membranes, collagen membranes have an enhanced ability support cell 
proliferation.15 Although commercial collagen membranes are widely used clinically, 
these bio-polymer membranes have been reported to be more easily contaminated by 
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bacteria, which leads to premature degradation, loss of barrier function and reduced 
bone formation.16 For example, Paul et al. showed that when collagen membranes 
became exposed, they became colonized by bacteria in the oral cavity, leading to the 
early membrane degradation and can result in limited or no healing of the bone after 6 
months.17 To overcome this shortcoming, antibiotics have been added in collagen 
membranes.18, 19 According to a randomized clinical trial, a collagen membrane 
saturated with metronidazole, a nitroimidazole antibiotic used to treat anaerobic 
bacteria and parasitic infections, failed to have better infection resistance than the 
collagen membrane without the antibiotic addition.18, 19 Though all commercial 
membranes in the discussed clinical examples have made improvement in 
periodontitis treatment, none of clinical studies have completely healed the 
periodontal defects.14, 20, 21, 22 New materials need to be explored that provide space 
protecting properties while also enabling growth and differentiation for cells 
necessary for the regenerating tissues in order to improve GBR treatments in restoring 
periodontal defects.  
1.3 Requirements for GBR membranes 
Ideally, to meet the clinical requirements, GBR membranes need to be nontoxic, 
biocompatible, support cell proliferation, as well as have adequate mechanical 
strength to act as a barrier between site for osteogenesis and the overlying gum 
tissue.23 In addition, a study has reported that membranes that exhibit 
nano-fiber/nano-porous structure are also advantageous to GBR membrane function.24 
The nanoscale fiber structure mimics the native fibrillar structure of extracellular 
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matrix to support cell attachments and growth and provides and additional advantage 
of having increased surface area for adsorption of proteins and or drugs.23 The 
nanofiber structure also results in porous structure for the communication between 
osteoblastic and fibrous cells and nutrition exchange while remaining cell occlusive.25  
Chitosan is a potential new material for GBR treatments. Chitosan is a 
polysaccharide polymer that exhibits many of the characteristics, e.g. biocompatible, 
non-toxic, bio-degradable, osteoconductive, and antimicrobial properties as well as 
the ability to be formed into nanofibrous structures that are ideal GBR membrane 
applications.24, 26 One of the most common ways to make nanofibrous chitosan 
materials is by a process called electrospinning. Prior to reviewing use of chitosan and 
chitosan nanofiber materials in GBR applications, a brief overview of electrospinning 
process will be provided followed by an overview of the chitosan polymer.  
1.4 Electrospinning 
Electrospinning is a method used for producing fibrous structure with nano- to 
micro- scale diameters.
27, 28, 29 Electrospinning uses high voltage electrostatic forces to 
spin a polymer solution into fibers that are collected to form fibrous membranes. 
Although this technique was first introduced in 1914, it has not been used for making 
tissue engineering scaffolds until recently by various research groups.23, 24, 25, 30 Basic 
apparatus of electrospinning include a spinneret, a fiber collector and a high-voltage 
power supply (Fig. 3).31 A spinneret is usually a needle tip connected to a syringe 
containing a viscous polymer solution. The polymer solution is fed through the needle 
tip at a steady slow flow rate under the control of a syringe pump.31 A fiber collector 
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is placed facing the spinneret a certain distance away and may be rotated to collect the 
fibers. In the consideration of the membrane application, various shape and forms of 
collector have been invented to produce membranes with required designs such as 
tubes, meshes, microbundles, and plain mats.32 A power supply provides high 
voltage/low current to create an electrostatic field between the spinneret and the 
grounded metallic collector during the electrospinning process. During spinning 
process, the polymer solution forms a pendent droplet at the needle tip under the 
voltage gradient is elongated into a conical shape by the electrostatic repulsive 
force.33 The conical shape is also well known as Taylor cone.33 Once the electrostatic 
force exceeds the surface tension of the polymer droplet, a charged jet is forced from 
the tip of the Taylor cone and then is stretched and whipped to the collector in a series 
of nano fibers.33 Generally, the fiber size is highly influenced by the applied voltage, 
polymer solution viscosity, distance between the fiber collector and the spinet, 
solution pumping rate, and even the room humidity.24 
1.5 Chitosan 
Chitosan is derived from chitin, a polysaccharide that is widely distributed in 
crustacean shells. The chitin polymer is composed predominantly of N-acetyl 
glucosamines and the polymer is insoluble in aqueous solutions.26 Treating chitin with 
strong base removes the acetyl groups resulting in a co-polymer of N-acetyl 
glucosamine and glucosamine. When more than 50% of the repeat units in the 
polysaccharide are glucosamine, the polymer is called ‘chitosan’. The mole fraction of 
glucosamines in the polymer is referred to as the degree of de-acetylation, DDA and 
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may range for 50% to 100% DDA (or 100% glucosamine repeat units). Since this 
biopolymer belongs to the alkali polysaccharide family, chitosan has bacteriostatic 
power.34, 35 It has been demonstrated that two oral pathogens, actinobacillus 
actinomycetemcomitans and stretococcus mutans, were inhibited at a chitosan (91.5% 
DDA) concentration as low as 0.001% in an in vitro study.34, 35 Additionally, chitosan 
is easily processed into membranes, nanofibers, nanoparticles, and sponges.24, 36, 37 
 
Fig. 3 Electrospinning apparatus in BAM laboratory  
1.6 Chitosan GBR membranes 
Chitosan has shown great potential in the GBR application. In a recent review 
article by Xu et al., several resorbable membranes of chitosan, polylactic acid, 
polyglycolic acid and lactide/glycolide copolymer that had been used in animal 
studies were compared.34 It was noted that the chitosan membranes helped to generate 










and osteoblasts along the new bone surface than either the polylactic acid, 
polyglycolic acid and lactide/glycolide copolymer membranes.34 
By combining chitosan and electrospinning, electrospun chitosan membranes 
have obvious combined advantages in GBR treatment. Electrospun chitosan 
membranes have shown improved cell compatibility in vitro and in vivo and have 
great potential for drug loading.38, 39, 40, 41 Shin et al. produced electrospun chitosan 
membranes and showed that the membranes had cyto-compatibility with hepatic cells 
in vitro, and was potentially viable for use in tissue formation.38 Norowski et al. 
produced a series of genipin crosslinked membrane and showed cyto-compatibility 
with osteoblast cells and biocompatibility and effective functional degradation ratio in 
vivo study.39, 40 Sangsanoh et al. compared schwannoma cell growth on several kinds 
membranes, demonstrating the cyto-compatibility of electrospun chitosan membranes, 
as well as prior than poly(3-hydroxybutyrate) and poly(3-hydroxybutyrate-co-3- 
hydroxyvalerate) electrospun fibers.41 However, while these studies have highlighted 
some potential advantages of the chitosan electrospun membranes for GBR, the 
clinical handibility of membranes has not been optimized.42 This limitation is largely 
attributed to the limited number of solvents used for making the chitosan 
electropinning solutions in order to have enough surface tension for electrospinning. 
1.7 The current problem of electrospun chitosan membranes 
Commonly, trifluoroacetic acid is the primary solvent for preparing the chitosan 
solution used for electrospinning chitosan membranes. Through research from Geng 
et al., their study reported using concentrated acetic acid as the main solvent for 
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successfully electrospinning chitosan into membranes.43 This work has not been 
replicated since it is difficult to get the chitosan dissolved in acetic acid to have 
enough surface tension strength and viscosity for the electrospinning process.44 On the 
other hand, chitosan dissolved in trifluoroacetic acid has the elastic and viscous 
properties for easily being stretched into fibers that is required for electrospinning.45 
Chitosan membranes made from trifluoroacetic acid need a post electrospinning 
chemical treatment to neutralize/remove the residual strong acid in the membranes. 
However, the trifluoroacetic acid salts (TFA salts) generated from the solvent in 
chitosan membrane are extremely hydrophilic and can easily induce the swelling and 
dissolution of the membrane fibers. The most widely used methods for the 
neutralization of electrospun chitosan membranes is by soaking in highly saturated 
NaOH or Na2CO3 solution. Sangsanoh et al. has explained the possible neutralization 
principle with highly saturated NaOH or Na2CO3 solution and then demonstrated that 
the 5 M Na2CO3 solution is more effective in keeping the fibrous structure of the 
chitosan membrane than the 5 M NaOH solution.46 In their theory, excess Na2CO3 in 
the saturated solution drives the continuous neutralization reaction toward the result 
of trifluoroacetic acid elimination, hence to exclude the swelling. They also indicted 
that the H2O molecules generated from NaOH neutralization process may be the 
reason for the swelling of the chitosan membrane. This theory is on the basis that the 
neutralization reaction happens quickly and the rapid rate may shield the effect of the 
water solvent. The assumption being that by avoiding the H2O molecules generated 
from the neutralization process it would be possible to avoid membrane swelling. In 
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reality evaluation though, the fibers still swell leading to loss of the nano fiber and 
structure. Other studies have tried to stabilize the fibers by crosslinking agents but success in 
maintaining the fiber structure has been limited.47, 48, 49, 50 
1.8 Aim 
In this investigation work, an innovative post electrospinning chemical treatment 
was evaluated for removing residual TFA salts and for maintaining the nano-fibrous 
structure. This treatment is focused on eliminating TFA salts and not just neutralizing 
the pH value from acid to mild neutral. Additionally, since amino groups in the 
chitosan are also likely to contribute to fiber swelling and loss of nano-fibrous 
structure. To minimize fiber swelling, triethylamine (TEA) in acetone will be used as the 
agent for dissolving the TFA salts since the salts are easily dissolved in the TEA/acetone 
solution but will not cause swelling of the fibers (Fig. 4). In addition, di-tert-butyl 
dicarbonate (tBoc) will be used to generate hydrophobic wrap around amino groups of 
the chitosan molecule. By blocking the amino groups, the hydrophilic character of the 
fibers will be reduced thereby further reducing/minimizing swelling of the chitosan 
nanofibers in the membrane.  
The objective of this project is to compare and evaluate the new-post-processed 
electrospun membranes by electron microscope for nano fiber structure as compared to 
typical base neutralized membranes. Cell compatibility and degradation of the 
new-post-processed electrospun membranes will be tested in vitro. Additionally, a simulated 
surgical fixation test will be use used to assess the mechanical strength and handability of the 
new post-processed chitosan membrane and effects of increasing membrane thickness.  
11 
 



























































CHAPTER 2: A NOVEL POST-ELECTROSPINNING TREATMENT TO 
IMPROVE THE FIBROUS STRUCTURE OF THE CHITOSAN MEMBRANE  
ABSTRACT 
Guided bone regeneration (GBR) membranes are employed in the bone generation of 
the periodontal tissues lost to injury or disease, and function as barriers between soft 
gingival tissues and bone regenerating space. Chitosan has been investigated as a GBR 
material due to its biocompatibility, degradability, and the ability to electrospun chitosan 
membranes with nanofibrous structure. However, residual acid salts from the 
electrospinning process make the as-spun material highly susceptible to swelling, 
dissolution, and loss of nano-fiber structure. This study investigated the use of a novel 
process to retain the nanofiber during removal of the acidic salts. Membranes were made 
by electrospinning 5.5wt% 71% degree of deacetylation (DDA) chitosan from a 70% 
trifluoroacetic aced (TFA) - 30% dichloromethane (DCM) solution at 26 kV. The 
membranes were first washed in triethylamine (TEA)/acetone to remove the TFA salts 
and then treated with di-tert-butyl dicarbonate (tBoc) to wrap the amino group to 
hydrophobic. Electron microscopy analyses showed that that fibers had 330 ± 130μm 
diameter and retained nanofibrous structure after immersion in distilled water overnight. 
FTIR confirmed the removal of the TFA salts. Membranes exhibited ability to support cell 
growth for at least 5 days and to degrade 23.7% after 7 weeks in vitro. A simulated 
surgical fixation test indicated that the TEA/tBoc treated chitosan membranes exhibited 
mechanical properties within range of current clinically used membranes.  




Guided bone regeneration (GBR) membranes are widely applied in the formation 
of the new bone in periodontitis treatments.1 Periodontal regeneration aims to reform 
the epithelial seal, acellular extrinsic fiber cementum, as well as to restore the alveolar 
bone height.1 Because of the faster growth rate of gingival connective tissue, GBR 
membranes are placed in between the soft tissue and regenerating bone to prevent the 
gingival connective tissue from intruding into the alveolar bone site.2  
In general, GBR membranes should have the characteristics to promote cellular 
functions, such as biocompatibility, biodegradability, non-toxicity, high porousity, 
interconnected pores in nano-size range in order to be cell occlusive, large surface 
area-volume ratio, and adequate mechanical strength.3 One of used ways to make the 
GBR membrane is electrospinning, which applies a high voltage to the polymer 
solution to spin the material into fibers. Chitosan is a natural polysaccharide used in 
electrospinning the GBR nano-fiber membranes because it is biocompatible, 
biodegradable, non-toxic and has been widely used in tissue scaffolds.4, 5, 6, 7  
Past studies have shown that chitosan nano-fiber membranes may be made via 
electrospinning processes.2, 4 These membranes in general have exhibited adequate 
biodegradation rates and good biocompatibility,2, 4, 8 though tear strengths of the 
membranes were 51% - 67% lower than that of commercially available collagen 
membranes.
8 Additionally, residual acidic salts from the electrospinning process make 
the nanofibers highly susceptible to swelling and dissolution. Trifluoroacetic acid 
(TFA) is widely used as the solvent for making the electrospinning chitosan solution 
14 
 
since it provides better viscosity property than other solvents such as acetic acid.5, 9 
TFA salts are generated with the chitosan polymer during the electrospinning process 
and these salts make the chitosan fibers extremely hydrophilic, and easily induce 
swelling and dissolution in aqueous solution. In the previous studies, saturated 
Na2CO3 and NaOH solutions have been employed as methods to neutralize and 
remove the TFA salts.10 Furthermore, several crosslinkers such as glutaraldehyde and 
genipin have also been used in order to try and stabilize the membranes in water 
condition.11, 12, 13, 14 However the success of the Na2CO3 and NaOH treatment and 
crosslinking strategies to stabilize fibers and prevent swelling have met with limited 
success and from our experience, were inconsistent in preventing fiber swelling and 
hard to reproduce. 
The goal of this research was to improve the nanofiber structure of the electrospun 
chitosan membranes and their mechanical properties. In order to improve and maintain 
nano-fibrous structure of the electrospun membranes, a new post electrospinning 
chemical treatment was evaluated. The new treatment used triethylamine (TEA) in an 
acetone solution coupled with a blocking of the chitosan amino groups by di-tert-butyl 
dicarbonate (tBoc) in a tetrahydrofuran (THF) solution. The TEA/acetone solution is used 
to remove residual acid salts from the spun membranes and the tBoc is used to prevent 
swelling of the fibers to maintain the nano-fibrous and nano-porous structure of the 
membranes. In addition, membrane thickness was increased in this research in order to 
increase the general mechanical strength. Electrospun membranes treated by 5 M 
Na2CO3 solution, were used as the control group.  
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Fiber morphology of the TEA/tBoc and carbonate treated membranes was 
measured by SEM and chemical/crystal structure evaluated by FTIR and XRD. 
Mechanical strength of the membranes based on surgical fixation tearing strength and 
degradation of the membranes were measured. In addition, the attachment/growth of 
cultured cells to the membranes over 5 days was also done to evaluate the 
biocompatibility. 
MATERIALS AND METHODS 
Electrospinning 
Electrospinning of the chitosan membranes was based on the method previously 
reported by our group.4, 8 Before the electrospinning, chitosan solution was prepared by 
gently mixing 5.50% (w/v) chitosan in 70% (v/v) trifluoroacetic acid and 30% (v/v) 
methylene chloride overnight. A 10 mL syringe with a 20 gauge, 3.81 cm blunt needle was 
used to load the solution. The rate of the syringe pump was set to 15 μL/min. Then the 
syringe was placed into the syringe pump. A 26kV voltage was connected between the 
needle tip and collection plate for electrospinning the solution into nanofibers. The needle 
tip was positioned a distance of 15 cm, from the collection plate. The collection plate was 
covered by nonstick aluminum foil and the fibers collected on the surface while rotating the 
plate at speed of 8.4 rpm to ensure random orientation. To increase the thickness of the 
membranes, three 10 ml volumes of the chitosan spinning solution were spun consecutively 
to produce an un-neutralized membrane approximately 0.7 ± 0.1 mm thickness and 
approximately 15 cm in diameter. The electrospinning process was shielded by ventilated 




Non-neutralized chitosan membranes was immersed in 10% (v/v) TEA/Acetone 
solution for 24 hours under mild magnetic stirring to completely remove all 
trifluoroacetate ions and rinsed in pure acetone for 2 hours. The rinsing procedure was 
repeated 2 times in order to remove excess TEA. The salt free chitosan membranes 
were then soaked in an acetone solution containing 2 g tBoc for 48 hours under mild 
magnetic stirring at 65°C. Membranes were rinsed by acetone for 2 hours and 
repeated 2 times to fully remove unreacted tBoc and dried in between two pieces of 
nylon net in air. 
For the control group, electrospun membranes were treated by saturated Na2CO3 
solution. Chitosan membranes were soaked in 5M Na2CO3 solution for 3 hours. Then 
the Na2CO3 solution was rinsed off by distilled (DI) water. To make sure that all the 
Na2CO3 solution was washed off, the rinsing process was repeated 3 to 4 times. Then 
the chitosan membranes were placed in-between two pieces of nylon net for drying in air. 
Scanning electron microscopy (SEM) 
The morphology of the fibers in the electrospun membranes was examined by 
scanning electron microscopy, SEM (EVO HD15, produced by Carl Zeiss AG). 
Disc-shaped specimens (~1cm diameter) of the chitosan membranes were attached to 
an SEM stub and coated with 8 nm gold-palladium. Three samples of each membrane 
from three different electrospun membranes were examined from 2500X to 6500X. In 
each sample, more than 20 fiber diameters were recorded. 
17 
 
Fourier Transform Infrared Spectroscopy (FTIR) 
To evaluate the extent of trifluoroacetic acid salt elimination, FTIR spectra were 
collected using a Nicolet 380 FTIR spectrometer (Thermo Electron Corporation). 
Spectra were collected for the chitosan starting powder, non-neutralized and 
neutralized chitosan membrane specimens. Four samples of each membrane were 
scanned from 500 cm-1 to 4000 cm
-1
 for 32 times. 
X-ray Diffraction (XRD) 
XRD was used to examine the crystallinity of the chitosan in the membrane fibers. 
Membranes neutralized by TEA/tBoc were first grounded into fine powders after 
immersing in liquid nitrogen by a mortar and pestle. Grazing angle reflection mode 
was the scanning mode. Data was collected from 2Θ = 4 to 30. Chitosan powders, 
non-treated membranes, Na2CO3 treated membranes, and TEA/tBoc treated 
membranes were examined (n = 4).  
Contact angle measurement 
Water contact angle measurements were used to measure the hydrophobic 
characteristics of the TEA/tBoc treated membranes and carbonate treated membranes. 
Contact angle of the water drop contacting the membrane surface was observed by 
VCA optima measurement machine (produced by AST products, INC) and the result 
was recorded. Four samples of each Na2CO3 treated and TEA/tBoc treated 




In vitro cell viability and proliferation 
Ethylene oxide gas sterilized disc-shaped chitosan membrane  
specimens (diameter = 1cm) were inserted in 24 well-plates for evaluating the growth 
of osteoblastic cells on the membranes over 5 days. Each plate contained both the 
experimental and control membranes. The membranes were fixed to the well bottom 
by round silicone rings, cut from silicone tubing. The rings had an inner diameter  
of 6 ± 2 mm. Membranes were rinsed in culture media three times, and then were 
seeded with Saos-2 human osteoblastic cells (Cat. No. HTB-85, ATCC, Manassas, VA, 
USA) at 1.5×105 cells/well (105 cells/mL × 1.5 mL media/well). Cells were grown in 
McCoy’s 5a medium (Modified) mixed with 10% FBS and 500 I.U. /mL  
penicillin, 500 μg/mL streptomycin, and 25 μg/mL amphotericin-B. Cell growth was 
measured using the Cell Titer GloTM luminescent cell viability assay (Promega, 
Madison, WI, USA). The assay was based on luciferin-luciferase reaction to measure 
the amount of oxidation of ATP, which is proportional to the amount of  
cells (n=4/sample per day). Data was reported in relative fluorescent units and 
compared in between the groups of TEA/tBoc treated membranes and Na2CO3 treated 
memrbanes. Cell viability and morphology were qualitatively observed by fluorescent 
microscopy using Live-Dead®stain (Molecular Probes, Eugene OR, USA).  
Surgical fixation test 
Since GBR membranes are generally secured to adjacent bone tissues using small 
tacks or screws,14, 15 a surgical fixation test was used to evaluate the mechanical 
properties of the TEA/tBoc treated membrane, as an indicator of clinical handability. 
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In this test, white oak wood was used as a bone analogue for tearing the membrane.16 
Using a mechanical test frame, the tensile force necessary to tear/break the membrane 
from the tack was measured before mechanical testing, each type of membranes was 
prepared to be the same size, 10×40 mm2 squares. 
In the surgical fixation test, the 10×40 mm2 square sample was tacked to a piece 
of 7.5×7.5×0.5 cm3 white oak as a bone analogue by a medical tack (AutoTac system 
kit, Biohorizons) at the position of 5 mm from the bottom edge and each sides. The 
wood with the sample was positioned in the lower clamp of the InstronTM model 4456 
mechanical test frame, and the free end of the membrane was positioned in the upper 
clamp (Fig. 1). The load cell used was 50 N and the extension rate was 1mm/min. 
Maximum load was recorded in Newton (N). After soaking in phosphate buffered 
saline (PBS) for 1 hour, membranes were tested in wet condition following the same 
procedures. In each surgical fixation test, three samples of each membranes were tested. 
Degradation  
The degradation of membranes (based on mass loss) was evaluated in PBS 
solution at 37 ˚C. Membranes were prepared into 3 cm2 squares and soaked in the 
PBS solution containing 100 μg/mL lysozyme, 500 I.U./mL penicillin, 500 μg/mL 
streptomycin, and 25 μg/mL amphotericin-B. At 1, 3, 5 and 7 week time points in 
PBS-lysozyme solution, membranes were retrieved, rinsed in DI water, dried for 48 
hours at 60 °C and then weighed (g) to record the change in mass. Membranes were 
then returned to the PBS-lysozyme solution and incubation time periods resumed. 
Although lysozyme in human physiology condition is not as high 100 μg/mL, this 
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high level was used to accelerate degradation and magnify potential differences over 
the course of the experiment. Mass fraction residue was used to show the result in 
grams. 
Statistical analysis 
ANOVA at the 0.05 level of significance was used in the statistical analysis of 
fiber diameters (n = 3/membrane), degradation (n = 4/membrane), contact angle (n = 
four/membrane) and mechanical (n = 3/membrane) tests.  
In cell proliferation test, two-way Analysis of variance (ANOVA) was used to 
analyze the cell proliferation data using type of membrane (n=4/membrane) as one 
factor and time as the second. As appropriate, Tukey’s post-hoc tests were used to 
distinguish significantly different groups. 
RESULTS 
SEM 
The membrane maintained the nano-fibrous structure after the TEA/tBoc treatment 
(Fig. 2 A). Fiber diameters were in the nano-scale. Though the fibers were fused and 
dissolved to some extent after soaking in DI water 12 hours, the membrane still kept the 
porous structure with fiber diameters remaining in the nano-scale size range (Fig. 2 B). 
The fiber diameters are 330±130 μm before contacting water and are 530±320 μm after 
soaking in water. In comparison, the membrane lost all the fibrous structure after the 
Na2CO3 treatment (Fig. 2 C). It is also noted that membranes only with the TEA treatment 
exhibited excess swelling or dissolution after twelve hours in water (Fig. 2 D), indicating 




The FTIR spectrum reveals the changes in the membrane during the TEA/tBoc treatment. 
After the TEA treatment, three transmittance peaks related to TFA salts at 720, 796 and 836 
cm-1 in the spectrum should be eliminated after TEA treatment. FTIR spectra revealed that the 
three transmittance peaks related to TFA salts at 720, 796 and 836 cm-1 disappeared after the 
TEA/tBoc treatment (Fig. 3). After the tBoc treatment, CO-NH group expressed as the peak 
at 1527 cm-1 and tBoc group expressed as the peaks at 1366.7 cm-1 and 1392.8 cm-1 in the 
spectrum has appeared, as well as the peak of C=O group at 1688 cm-1 has increased.  
XRD 
Crystallinity of chitosan was mainly determined by the peak intensity differences  
at 2Θ = 20 and the lowest point of the baseline (amorphous region) at 2Θ = 12 
normalized to the peak intensity in XRD. Although the spectra of the chitosan powder 
exhibited both peaks at 2Θ = 12 and 2Θ = 20, all electrospun chitosan membranes had 
lost the peak at 2Θ = 20. These results suggested that the chitosan had less 
crystallinity structure after being electrospun into the membrane (Fig. 4). 
Contact Angle measurement 
Results of the water contact angle test are shown in Figure 5. The contact angle of 
the water drop on the TEA/tBoc treated membrane surface was 119.4 ±14 degrees 
(Fig. 5 A). The contact angle of the Na2CO3 treated membrane was 95.9 ± 10.8 
degrees (Fig. 5 B), which is significantly less than the contact angle result of 
TEA/tBoc treated membranes (p = 6.74×10-5). 
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In vitro cell viability and proliferation 
Results of the cell growth on the TEA/tBoc treated and the Na2CO3 treated 
membranes are shown in Figure 6 and 7. Viability staining revealed high cellular 
viability of osteoblasts for both membrane types (Fig 6). Cell proliferation, based on 
cellular ATP levels, indicated a statistically lower number of cells on day 1 and day 3 
for the TEA/tBoc treated membrane as compared to the Na2CO3 treated  
membranes (p = 10-6 at day 1 and p = 4.17×10-5 at day 3) (Fig. 7). However, there was 
no statistical difference in the number of cells between the two membranes types at 
day 5 based on relative luminescence units (p = 0.13). 
Surgical fixation test 
In the surgical fixation test, the maximum loads normalized to the thickness are 
shown in Figure 8 A. The average tearing strength of the TEA/tBoc treated 
membranes was 62.1 N/mm (± 1.87 N/mm) in dry condition and 28.0 N/mm (± 0.44 
N/mm) in wet condition. Averaging the tearing strength of dry and wet condition, the 
average tearing strength of TEA/tBoc treated membranes was 45.1 N/mm (± 1.02 
N/mm). The tearing strength of commercial collagen BioGuide membrane was 133.9 
N/mm (± 21.5 N/mm) in dry condition, and 124.5 N/mm (± 8.61N/mm) in wet 
condition. The tearing strength of the PLA GUIDOR membrane was 34.9 N/mm in 
dry condition, and was 22.2 N/mm in wet condition. The tearing patterns of the 
membranes were shown in Figure 8. According to the ANOVA analysis, the tearing 
strength of TEA/tBoc membranes was significantly less than that of BioGuide collage 
membranes in dry (p = 0.0045) and wet (p = 0.0079) condition. There was no 
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significant difference in between the dry and wet condition of BioGuide collagen 
membrane (p = 0.63), but there were significant differences between the dry and wet 
condition of TEA/tBoc treated membranes (p = 1.63×10-4). 
Degradation 
The degradation experiment showed that the TEA/tBoc treated membranes 
decreased in weight in a similar pattern to the Na2CO3 treated membrane during the 7 
weeks (Fig. 9). There were no statistical differences (p = 0.21) between the decreased 
weights of the both groups at each week point. 
DISCUSSION 
The objective of this work was to evaluate a novel post-spinning treatment to 
remove acidic acid salts and retain nano-fiber structure of electrospun chitosan 
membranes. This work also evaluated increasing the thickness of the membranes to 
improve their handablity and mechanical properties. 
We used three 10 mL volumes of chitosan solution to electospun sequentially to 
make thicker membranes as compared to membranes made by our group previously.4 
These thicker membranes may have been produced by electrospinning a single 30 mL 
chitosan solution directly. However the electrospinning process of chitosan requires 
close monitoring to ensure constant spinning process and the larger volumes would 
have required an undue extended time for monitoring the spinning process. While 
sequential spinning to build up the membrane in layers added time to the overall 
process, ability to monitor the spinning process in shorter time intervals was an 
advantage. Additionally, SEM examination of torn edges of the TEA/tBoc treated 
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membranes spun from sequential solutions did not exhibit any layering effect and the 
fibers were of similar nanometer diameter size (data not shown). This observation 
indicated that electrospinning a thicker membrane using three sequential solutions did 
not result in distinct layers and nor altered inner fibrous structure of the membrane.  
The post treatment process used TEA to remove the TFA salts, followed by tBoc 
to wrap the amino group. Since chitosan is not dissolved in organic solutions, all the 
treatments were undertaken in the organic solvents (acetone/THF) to prevent swelling 
by water. TFA salts in electrospun chitosan membranes may be removed by a strong 
base. TEA was chosen as a base to remove the TFA salts because the TEA has a pKa 
around 11, which is greater than the amino groups of chitosan (pKa ~ 6.5) and thus 
will form stronger salt with the TFA than the chitosan. Since the TEA-TFA salts are 
soluble in acetone, the TFA will be leached out of the chitosan and bound to the TEA 
and then rinsed off in the acetone solution. After removing the TFA, the free amines 
of the chitosan were protected by the tBoc reaction to reduce the overall free-amino 
groups and to reduce the overall hydrophilicity of the chitosan polymer. The protected 
amino groups of TEA/tBoc treated chitosan membranes are stable in neutral or basic 
condition, but not in strong acid condition thus providing protection for the fibers 
from swelling in water. 
SEM examination of the membranes demonstrated that the TEA/tBoc process 
succeeded in retaining the nanofibrous structure, especially compared with the 
traditional Na2CO3 treatment. FTIR analyses showed that the TFA salts were removed, 
and in vitro cell culture and degradation tests demonstrated that the TEA/tBoc treated 
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membranes were cytocompatible and degradable. These results strongly suggest that 
the TEA/tBoc treatment may be an effective means for retaining nanofibrous structure 
of chitosan electrospun membranes for GBR applications. 
SEM examination of the fiber structure of the TEA/tBoc and Na2CO3 treated 
membranes showed that the TEA/tBoc treated membranes retained nanofibrous 
structure after treatment and even after soaking in aqueous solution overnight, 
whereas the Na2CO3 treated membranes exhibited much deterioration of the nanofiber 
structure. Some swelling and fusion of the fibers of the TEA/tBoc treatment materials 
occurred after soaking water overnight, but the diameters of the fibers remained in the 
nano-scale range. Since that the fiber diameters of extra cellular matrix are  
from 80 to 500 nm, and thinner fibers have been linked to increased biocompatibility 
of a material,17 the fibrous structure we achieved was consistent with mimicking the 
extracellular matrix and holds promise for improving barrier membrane properties. 
Our results contrast with the results from Norowski et al., in which genipin in 
conjuction with Na2CO3 was used to try and stabilize the fibers, but with only limited 
success.4 In Volpato’s work, NH4OH was used to neutralize the TFA salts, the fiber 
diameter increased to 1 μm after the treatment.17 Austero, tried to use several 
crosslinkers (genipin, hexamethylene-1,6-diaminocarboxysulphonate and 
epichlorohydrin) to increase the water stability but the membranes still lost most 
fibrous structure after the basic treatment.18  
 Since the hydrolysis of the TFA salts are considered the reason for membrane 
swelling and water dissolution, TEA treatment was used to remove all the TFA salts in 
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the chitosan membrane. The FTIR result has shown that all the peaks related to the 
TFA salts, which were at 720, 796 and 836 cm-1 in the spectrum, have completely 
gone after the TEA treatment, indicating that all the TFA salts were eliminated after 
the treatment. However, chitosan membranes at this stage still lost most of the fibrous 
structure after contacting water for overnight. The amino groups were then regarded 
as leading to the swelling and dissolution since the amino group is extremely 
hydrophilic. It was expected that the amine group would be protected by the tBoc 
treatment. The peaks around 1600 cm-1 showed an increased height after the tBoc 
treatment in the spectrum. These peaks indicated the presence of the tBoc molecule, 
which was also confirmed by the increase in water contact angle and hydrophocitiy 
characteristics. Since tBoc contains large butyl groups which are hydrophobic, their 
presence on the chitosan fibers would result in an increased water contact angle and a 
more hydrophobic surface. The retention of the nanofiber structure observed in the 
SEM is attributed in large part to the tBoc wrap and increase in hydrophobic 
characteristics. Chen et al., have depicted the disappeared three peaks related TFA 
salts after the TFA salts were totally removed.19 Ju et al. have proved the existence of 
tBoc wrap by the peaks at the similar position with ours in their work.20 
The diffractograms of XRD result showed that there was less crystallinity after 
making the chitosan powder into the electrospun membranes. The untreated 
electrospun membrane lost the peak at 2Θ=20, and the same to the treated membranes, 
which showed that the both TEA/tBoc and Na2CO3 treatments did not influence the 
crystallinity of the chitosan. Decreased crystallinity is associated with more open 
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molecular structure, which resulted to increased degradation, less resistance to 
swelling and reduced tearing strength. Compared with the diffractograms of the 
electrospun chitosan membrane from Zhou, we have similar patterns with theirs.18 
Zhang also reported a similar XRD pattern, the peak in the diffractogram of chitosan 
powder at 2Θ=20 was lost after electrospinning.21 In both studies, water swelling 
problem was observed.18, 21 
Clinically, surgical tacks are one common method to secure the membrane on the 
bone during treatment.22, 23 Surgical tack test provides a means to simulate the how 
the membrane will be handled and used in clinical operation. The tearing strength of 
the TEA/tBoc treated membrane with increased thickness was 55.3% less than the 
tearing strength of the commercial collagen Bio-Guide membrane in dry condition, 
and was 77.5% less than the tearing strength of the commercial collagen Bio-Guide 
membrane in wet condition. The tearing strength of the PLA GUIDOR membrane  
was 43.8% less than the tearing strength of the TEA/tBoc treated membrane with 
increased thickness in dry condition and was 20.7% less than the tearing strength of 
the TEA/tBoc treated membrane in wet condition. The tearing strength of the 
TEA/tBoc treated membrane in dry condition was significantly more than that after 
soaking in PBS for 1 hour. According to the fact that swelling decreased the fiber 
strength, this result was consistent with the SEM result that the membrane fibers swell 
after soaking in water. Though the tearing strength of TEA/tBoc treated membranes 
was significantly lower than the BioGuide collagen membranes in both dry and wet 
condition, it was similar to the result of GUIDOR PLA membranes. Hence, the tearing 
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strength of TEA/tBoc treated membranes was in the range of clinical requirement, 
suggesting that the membrane was able to be stabilized on bone by tacks and function 
as a secure cover. By examining the torn patterns of the membranes, the BioGuide 
collagen membrane presented extremely elasticity during the tearing process (Fig. 8 C). 
TEA/tBoc treated membranes had the similar torn patterns with the collagen 
membranes but lower elasticity (Fig. 8 B), as well as the GUIDOR PLA membrane 
was torn in the middle part of the membrane instead of the tearing edge (Fig. 8 D). 
The torn patterns relate to the clinical handability. With the similar tearing strength, 
TEA/tBoc treated membranes with increased thickness could be easier fixed in the 
wound and keep better coverage function than the GUIDOR PLA membranes. The 
tearing strength of Na2CO3 treated chitosan membrane electrospun by 10 mL chitosan 
solution from Norowski et al. was less than 10 N/mm.8 However, they get this data 
from the suture test instead of the surgical fixation test. In order to make the 
comparison, we tested the tearing strength of the chitosan membranes electrospun  
by 30 mL solution (treated by the both TEA/tBoc and Na2CO3 methods), shown 5 to 7 
times more than the tearing strength of the Na2CO3 treated chitosan membrane 
electrospun by 10 mL chitosan solution (data not shown). 
Five days osteoblast growing study evaluated the cell compatibility of the GBR 
membranes (Fig. 6). The TEA/tBoc treated membrane showed less osteoblast 
proliferation than the Na2CO3 treated membrane at day 1 and day 3, but was not 
different at day 5. Although it is not clear why this happened, since the TEA/tBoc 
treated membranes are hydrophobic at least initially, the lower growth of cells at  
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day 1 and 3 may reflect a lower number and, or slower rate of cell attachment to the 
membranes as compared to the carbonate treatment membranes. The swelling of the 
fibers in water overnight may suggest that they become less hydrophobic. Cells grow 
better on hydrophilic surface than hydrophobic surface. Hence after a brief period of 
time, the cells were able to attach well to the tBoc treated membranes and proliferate 
normally so that there was no difference between membranes by day 5. The high 
viability and normal morphology were confirmed visually via the live/dead  
stain (Fig. 7). 
The degradation study did not show that the TEA/tBoc treatment had significant 
influence on the degradation rates compared with the Na2CO3 treatment. At the end of 
seven weeks, the TEA/tBoc treated membranes lost 23.9% of the original weight, as well as 
the Na2CO3 treated membranes lost 43.4%. From earlier work of our group, one layer 
Na2CO3 treated membranes lasted 16-20 weeks in vivo until showing significant 
degradation.7 Since TEA/tBoc treated membranes showed similar behavior, it is expected 
that the degradation profile of the TEA/tBoc treated membrane would be able to meet the 
target of 4-6 month healing time frame as an effective barrier function. 
CONCLUSION 
 A new post-electrospinning treatment to the chitosan membrane was assessed in 
this research, which has successfully preserved the porous structure in the 8 hours DI 
water environment with good cell compatibility and degradation rate. Also, the tearing 
strength of the chitosan membrane was significantly improved compared with the 
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Fig. 2 SEM graphs of chitosan membrane treated by A. TEA/tBoc, 6000X, B. 
TEA/tBoc after soaking in water overnight, 6500X, C. 5M Na2CO3, 6500X and D. 









Fig. 3 The FTIR spectra of the TEA/Boc treated membrane in different treatment 
procedures, non-treated chitosan membrane, membrane after removal of TFA (TEA 
treatment), and membrane with tBoc protection (tBoc treatment). The transmittance 
peaks related to TFA salts at 720, 796 and 836 cm-1 disappeared after the TEA/tBoc 
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Fig. 5 Graphs of the water contact angle on the surface of the A. TEA/tBoc treated 








Fig. 6 Live/Dead graphs (A. chitosan membrane treated by TEA/tBoc, B. chitosan 
membrane treated by Na2CO3) of the cell viability observed at 40X. Green dots were 






   




































Fig. 8 A. Surgical fixation test results and the tear patters of the B. TEA/tBoc treated 
membrane, the C. commercial collagen membrane and the D. commercial PLA 
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Fig. 9 Results of the membrane weights at 1 week, 3 weeks, 5 weeks and 7 weeks in 
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CHAPTER 3: FUTURE STUDIES 
This study needs further examination in the future. The time frame of TEA/tBoc 
treated membranes losing their fibrous structure is still unknown and should be 
investigated. The fibrous structure of membranes soaked in PBS for 1, 2, 3, 5, 7, 14, 
and 21 days should be observed under the SEM. Degradation tests in this study applied 
vacuum oven at 60 °C to dry the samples. It is not clear whether this 60 °C would affect the 
chitosan degradation. Hence, another method used to evaluate the degradation ratio 
should be used as verification.  
Other than considering the cyto-compatibility, the investigation of oral bacterial 
reacting with TEA/tBoc membrane will be needed. By increasing the hydrophobic 
properties of the nanofibers, the ability of the bacteria to attach and grow may be 
reduced and thereby provide an additional advantage for reducing infectious 
complications of GBR membranes.  
The fixation test showed that our membranes had significantly lower tearing 
strength than BioGuide collagen membrane. Ways to improve the tearing strength 
may still be needed. Ways to improve the mechanical properties may be by adding 
crosslinkers or calcium phosphate mineral.42 TEA/tBoc membranes showed adequate 
cell compatibility in vitro, though it is necessary to know whether they will perform 
well in vivo. Animal study of small animals (rats) and larger animals (dogs) will be 
required to test the biocompatibility in vivo in addition to in vitro compatibility results. 
Calvaria defect models could be used in the rat model to evaluate biocompatibility 
and inflammation response. The functional use as a GBR membrane in periodontal 
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defect could be studied using a canine model. In addition, loading anti-inflammation 
and antibiotic drugs to membranes may also be used to improve trauma healing and 
prevent infection.  
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CHAPTER 4: CONCLUSION 
The TEA/tBoc treatment has successfully preserved the nanofibrous structure of 
the chitosan membrane in water condition by removing the TFA salts and wrapping 
the amine group. Adequate cell compatibilities and degradation rates have been 
observed with these improved membranes. Also, increasing the thickness of the 
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Mechanical test - Suture pull out test 
In clinical, membranes were also secured by suture other than tacks. The suture 
pull out test was another way to evaluate the tearing strength of membranes. The 
previous study of our group has tested the suture strength of Na2CO3 treated 
membranes electrospun by 10 mL chitosan solution and a collagen membrane 
(Biomend, Zimmer Dental).1 Based on the results of previous study, suture strength of 
TEA/tBoc and Na2CO3 treated membranes electrospun by 30 mL chitosan solution 
were tested here. 
Method 
Before the test, a single suture was made 5mm from the top edge and each sides 
of the prepared membranes. The suture was a 70 cm general closure monofilament 
polydioxanone (PDS II, Ethicon, Z-341) with taper ct-1 needle and 1(4.0 metric) 
gauge. The sample with the suture through was clipped in the bottom claw of the 
InstronTM model 4456 mechanical test frame. Mean-while, the un-knotted side of the 
suture was affixed to the upper claw of the mechanical test frame (Fig. 1). The load 
cell of the dry specimen suture pull out test was 50 N and the extension rate  
was 1mm/min. Maximum load was recorded in Newton (N). 
Result 
Results of the suture pull out tests of different chitosan membranes and a 
commercial collagen membrane are shown in Fig. 2. In this figure, results from a 
previous study of a Na2CO3 treated membrane electrospun by 10 mL chitosan solution 
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was included for reference. Compared to the degradable collagen membrane, both 
types of chitosan membranes with increased thickness exhibited 65-72% lower suture 
strengths. The torn edges for the TEA/tBoc and Na2CO3 treated membranes were 
examined by SEM (Figure 3). 
Discussion 
The results of the suture pull out strength proved that the membranes with 
increased thickness improved by 5X the tearing strength than the membrane 
electrospun by 10 mL chitosan solution for the same post Na2CO3 electrospinning 
treatment (Fig. 2). This indicates that increasing the thickness of the membrane 
benefits the tearing strength of the membranes. There was no significant difference in 
the suture strength between the TEA/tBoc treated and Na2CO3 treated membranes. By 
observing the torn edge under the SEM, broken fibers could be observed at the torn 
edge of the TEA/tBoc treated membrane (Fig. 3 A B), whereas only the flat fused 
surface could be seen at the torn edge of the Na2CO3 treated membrane (Fig. 3 C). 
The torn edge of the TEA/tBoc treated membrane proved that the tBoc process have 
protected all the fibers including the inner layers. Comparing with the Biomend 
crosslinked collage membrane, even chitosan membranes with increased thickness 
were significantly less (65%-72%) in suture strength. Suture strength of TEA/tBoc 
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Fig. 1 The setup of suture pull out test. Load cell: 50N. Extension rate: 1mm/min.  
 































Fig. 3 SEM graphs of the TEA/tBoc treated membrane tearing edge after suture pull 
out test, A. 487X, B. 600X, and C. the Na2CO3 treated membrane tearing edge after 
suture pull out test, 2500X. 
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